In 2020, Credo Biomedical debuted its rapid flu test in the international arena. This series looks at the challenges that fledgling ventures face if they choose to go global and why some companies take the leap. Follow the founders of each company as they navigate key goals and examine whether they succeed in meeting the real-time challenges of product development and sales that they set for themselves.
Celebrating 15 Years of Innovation: Extended Warranty Program
April 1, 2026
Since 2011, Credo Diagnostics Biomedical has been dedicated to advancing molecular diagnostics through innovative Point-of-Care testing solutions. Over the past 15 years, we have worked
